Total Funding
4
50
Total FundingSeries C raised
Growth Score
-1 pts
Heat Score
-6 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
119341
Harbor MedTech develops and commercializes tissue regeneration products for chronic wounds, hernia and joint repair, and more.
Jerry Mezger: President & CEO- Jim Klingler: Co-Founder, Vice President, CFO
About the Company
Harbor MedTech develops and commercializes tissue regeneration products for chronic wounds, hernia and joint repair, and more.
It offers NeuvoCell, a wound therapy for chronic wounds, such as diabetic, venous, and pressure ulcers; products for hernia and joint repair, orthopedic soft tissue repair, breast reconstruction, and urogynecological
repair; and Architect, a collagen matrix for treatment of partial and full-thickness skin wounds. Harbor MedTech, Inc. has a strategic partnership with Edwards Lifesciences.
The company was founded in 2010 by Jim Jungwirth and Keith Myers and is based in Irvine, California.
